Crescent Capital (CCAP) analyst forecast and price target
Analyst forecast
Consensus of 7 analyst ratings
Based on 4 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Keefe, Bruyette & Woods | Downgraded | Outperform → Market Perform | $12.00 from $13.00 | Aug 17, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $11.00 from $12.00 | Aug 12, 2026 |
| B. Riley Securities | Maintained | Neutral | $12.50 from $13.50 | Aug 12, 2026 |
| Ladenburg Thalmann | Maintained | Buy | $14.00 from $15.00 | Aug 12, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $13.00 from $15.00 | Jun 16, 2026 |
| Oppenheimer | Downgraded | Outperform → Perform | $16.00 from $19.00 | May 15, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $12.00 from $13.00 | May 15, 2026 |
| Ladenburg Thalmann | Maintained | Buy | $15.00 from $16.00 | May 15, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $15.00 from $15.50 | Apr 16, 2026 |
| B. Riley Securities | Initiated Coverage | Neutral | $13.50 | Mar 30, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $13.00 from $14.00 | Feb 27, 2026 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $15.50 from $17.00 | Nov 14, 2025 |
| Oppenheimer | Maintained | Outperform | $19.00 from $20.00 | Nov 14, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $14.00 from $15.00 | Nov 14, 2025 |
| Clear Street | Initiated Coverage | Buy | $16.50 | Sep 5, 2025 |
| Keefe, Bruyette & Woods | Downgraded | Outperform → Market Perform | $17.00 from $18.50 | May 16, 2025 |
| Raymond James | Maintained | Outperform | $17.00 from $20.00 | May 16, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $15.00 from $16.00 | May 16, 2025 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $18.50 from $20.00 | Apr 8, 2025 |
| Keefe, Bruyette & Woods | Maintained | Outperform | $20.00 from $19.00 | Nov 25, 2024 |
Frequently asked questions
What is the price target for CCAP stock?
The average 12-month analyst price target for Crescent Capital (CCAP) is $12.38, with a high estimate of $14.00 and a low of $11.00, across 4 analysts.
Is CCAP a buy, sell, or hold?
Analysts covering Crescent Capital currently average a Hold rating: 3 buy, 4 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CCAP?
The average price target of $12.38 implies 16.31% upside from the last price of $10.64.
What is the latest analyst rating on CCAP?
On Aug 17, 2026, Keefe, Bruyette & Woods downgraded Crescent Capital to Market Perform with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.